Search results for "Drug Interactions"
Guidance released on use of new oral anticoagulants in nonvalvular afib
The European Heart Rhythm Association published guidance last week on using new oral anticoagulants in patients with nonvalvular atrial fibrillation.
https://immattersacp.org/weekly/archives/2013/05/07/6.htm
7 May 2013
New warnings on acetaminophen, ketoconazole
This regulatory update covers a rare but serious skin reaction for acetaminophen, as well as new limits on ketoconazole due to risks of liver injury.
https://immattersacp.org/archives/2013/10/fda.htm
1 Oct 2013
Anticoagulant choice for stroke won't be easy for some time
New agents improve upon warfarin, but they are expensive and lack antidotes for urgent reversal. There is no clear winner among the current options, and more are on the way.
https://immattersacp.org/archives/2013/10/shm.htm
1 Oct 2013
New afib guideline covers novel anticoagulants, ablation
A new guideline for managing nonvalvular atrial fibrillation recommends using a more comprehensive risk calculator, diminishing aspirin's role, adding 3 new anticoagulants to treatment options, and increasing use of radiofrequency ablation.
https://immattersacp.org/weekly/archives/2014/04/01/4.htm
1 Apr 2014
New methadone safety clinical practice guideline released
New guidelines for prescribing methadone for opioid addiction and pain management offer advice for primary care and specialty providers about safety and electrocardiogram monitoring to identify patients at high risk for cardiac problems.
https://immattersacp.org/weekly/archives/2014/05/06/2.htm
6 May 2014
New cholesterol guideline focuses on statin intensity, not LDL
A new cholesterol guideline focuses on the intensity of statin therapy, the 10-year risk or lifetime risk, and the balancing of those benefits with the risks and side effects of the medicine. Also, the therapeutic response should be considered when managing hyperlipidemia.
https://immattersacp.org/archives/2014/06/cholesterol.htm
1 Jun 2014
Rivaroxaban has similar safety, efficacy versus warfarin in older and younger nonvalvular afib patients
Rivaroxaban appears to have similar safety and efficacy compared with warfarin in both older and younger patients with nonvalvular atrial fibrillation, although stroke and major bleeding rates were higher in the former group, a new study found.
https://immattersacp.org/weekly/archives/2014/06/10/6.htm
10 Jun 2014
life expectancy. “There is a general denial ofdeath, denial ...
An editorial stated that since polypharmacyhas become ubiquitous, better surveillancefor drug-drug interactions is needed, andnoted that the true costs of hypoglycemiaextend beyond immediate treatment.“Serious hypoglycemia substantially lowershealth-related quality
https://immattersacp.org/archives/2014/10/acpi-201410-puzzle_t2.pdf
23 Sep 2014
AHA/ASA releases updated guidelines for primary prevention of stroke
The American Heart Association/American Stroke Association last week released updated guidelines on the primary prevention of stroke that included new recommendations on the use of statins, blood pressure management, and risk stratification for atrial fibrillation.
https://immattersacp.org/weekly/archives/2014/11/04/4.htm
4 Nov 2014
Patients on tramadol may be more likely to be hospitalized for hypoglycemia
Patients who began taking tramadol were significantly more likely to be hospitalized for hypoglycemia than those prescribed codeine, a recent study found.
https://immattersacp.org/weekly/archives/2014/12/16/1.htm
16 Dec 2014